Issue 10, 2021, Issue in Progress
From the journal:

RSC Advances

Retraction: LncRNA ZEB2-AS1 regulates the drug resistance of acute myeloid leukemia via the miR-142-3p/INPP4B axis

Laura Fishera  

a Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, UK
E-mail: advances-rsc@rsc.org

Abstract

Retraction of ‘LncRNA ZEB2-AS1 regulates the drug resistance of acute myeloid leukemia via the miR-142-3p/INPP4B axis’ by Kai Wang et al., RSC Adv., 2019, 9, 39495–39504, DOI: 10.1039/C9RA07854A.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D1RA90063C
Article type
Retraction
Submitted
25 Jan 2021
Accepted
25 Jan 2021
First published
01 Feb 2021
This article is Open Access
Creative Commons BY license

RSC Adv., 2021,11, 5762-5762

Permissions

Request permissions

Retraction: LncRNA ZEB2-AS1 regulates the drug resistance of acute myeloid leukemia via the miR-142-3p/INPP4B axis

L. Fisher, RSC Adv., 2021, 11, 5762 DOI: 10.1039/D1RA90063C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements